News

Law

Asset Management

Investment Banking

Wealth

Hedge Funds

People

Newsletters

Events

Lists

Private Equity

Stanley Capital swoops on pharma sector for fourth deal

Mid-market firm eyes further acquisitions as technology reshapes medicine

Stanley Capital Partners has swooped on a US pharma company in the latest sign of buyout appetite for the healthcare sector, Financial News sister title Private Equity News can reveal.

The London-based private equity house has acquired Drug Safety and Pharmacovigilance Services Solutions from Astorg and Nordic Capital-backed Clario.

WSJ Logo